FindTrial
Sign In

Mailuotong Keli in the treatment of asymptomatic myocardial ischemia in patients with coronary heart disease

Mailuotong Keli in the treatment of asymptomatic myocardial ischemia in patients with coronary heart disease: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094675
Enrollment
Unknown
Registered
2024-12-26
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asymptomatic myocardial ischemia in patients with coronary heart disease.

Interventions

Intervention group:Mailuotong Keli
Control group:Gold standard treatment

Sponsors

Foshan Maternity & Child Healthcare Hospital,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1.The patient met the diagnostic criteria of coronary heart disease in the 9th edition of Internal Medicine, and had a history of coronary heart disease. 2.Asymptomatic myocardial ischemia was diagnosed by treadmill exercise testing. 3.Patients and their families were informed about the study and signed informed consent. 4.Age less than 80 years. 5.Good spirits and adherence.

Exclusion criteria

Exclusion criteria: 1.People who are allergic to drugs. 2.Women in pregnancy. 3.Severe abnormal liver and kidney function. 4.People with mental illness. 5.No informed consent was obtained.

Design outcomes

Primary

MeasureTime frame
Myocardial ischemia was improved;—

Secondary

MeasureTime frame
Serum total cholesterol;Triglycerides;Hemodynamic indicators;Adverse events;—

Countries

China

Contacts

Public ContactLei Xiao

Foshan Maternity & Child Healthcare Hospital,

greenhot@163.com+86 757 22978113

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026